These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33596152)

  • 21. Applicability of ancestral genotyping in pharmacogenomic research with hormonal contraception.
    Lazorwitz A; Aquilante CL; Shortt JA; Sheeder J; Teal S; Gignoux CR
    Clin Transl Sci; 2021 Sep; 14(5):1713-1718. PubMed ID: 33650294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of rifampin on serum etonogestrel concentrations and biomarkers of ovulation among contraceptive implant users: A pharmacokinetic and pharmacodynamic study.
    Lazorwitz A; Sheeder J; Teal S
    Contraception; 2023 Jul; 123():110035. PubMed ID: 36997081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
    Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D;
    Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial.
    Hou MY; McNicholas C; Creinin MD
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):361-6. PubMed ID: 27419258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.
    Meirik O; Brache V; Orawan K; Habib NA; Schmidt J; Ortayli N; Culwell K; Jackson E; Ali M;
    Contraception; 2013 Jan; 87(1):113-20. PubMed ID: 23063337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of rectovaginal endometriosis with the etonogestrel-releasing contraceptive implant.
    Ferrero S; Scala C; Ciccarelli S; Vellone VG; Barra F
    Gynecol Endocrinol; 2020 Jun; 36(6):540-544. PubMed ID: 31711348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant.
    Flores JB; Balderas ML; Bonilla MC; Vázquez-Estrada L
    Int J Gynaecol Obstet; 2005 Sep; 90(3):228-33. PubMed ID: 16043175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An exploratory analysis on the influence of genetic variants on weight gain among etonogestrel contraceptive implant users.
    Lazorwitz A; Dindinger E; Harrison M; Aquilante CL; Sheeder J; Teal S
    Contraception; 2020 Sep; 102(3):180-185. PubMed ID: 32407811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical eligibility criteria for new contraceptive methods: combined hormonal patch, combined hormonal vaginal ring and the etonogestrel implant.
    Gaffield ME; Curtis KM; Mohllajee AP; Peterson HB
    Contraception; 2006 Feb; 73(2):134-44. PubMed ID: 16413844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement.
    Bahamondes L; Brache V; Ali M; Habib N;
    Contraception; 2018 Sep; 98(3):181-187. PubMed ID: 29777663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of etonogestrel implant beyond approved duration: prolonged contraceptive effectiveness.
    Ribeiro BC; Nogueira-Silva C; Afonso H; Silva PO; Reis ID
    Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):309-310. PubMed ID: 30203680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etonogestrel contraceptive implant uptake and safety among solid organ transplant recipients.
    Lew J; Sheeder J; Lazorwitz A
    Contraception; 2021 Nov; 104(5):556-560. PubMed ID: 34147509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant.
    Moray KV; Chaurasia H; Sachin O; Joshi B
    Reprod Health; 2021 Jan; 18(1):4. PubMed ID: 33407632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etonogestrel implant use in women primarily choosing a combined oral contraceptive pill: A proof-of-concept trial.
    Chen MJ; Hsia JK; Creinin MD
    Contraception; 2018 Jun; 97(6):533-537. PubMed ID: 29496473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of the etonogestrel contraceptive implant in obese women.
    Mornar S; Chan LN; Mistretta S; Neustadt A; Martins S; Gilliam M
    Am J Obstet Gynecol; 2012 Aug; 207(2):110.e1-6. PubMed ID: 22717269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etonogestrel contraceptive implant-associated secondary anorgasmia.
    Chapa HO; Ramirez A; Dawson D
    Contraception; 2017 Oct; 96(4):254-256. PubMed ID: 28666796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon.
    Wenzl R; van Beek A; Schnabel P; Huber J
    Contraception; 1998 Nov; 58(5):283-8. PubMed ID: 9883383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
    Floyd JL; Beasley AD; Swaim LS; Turrentine MA; Nijjar JB
    Obstet Gynecol; 2020 Jun; 135(6):1275-1280. PubMed ID: 32459418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users.
    Mansour D; Bahamondes L; Critchley H; Darney P; Fraser IS
    Contraception; 2011 Mar; 83(3):202-10. PubMed ID: 21310280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration.
    McNicholas C; Maddipati R; Zhao Q; Swor E; Peipert JF
    Obstet Gynecol; 2015 Mar; 125(3):599-604. PubMed ID: 25730221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.